TITLE

Differential Expression of Thymidylate Synthase in Colorectal Tumors and Matched Lymph Nodes: Impact on Adjuvant Treatment

AUTHOR(S)
Trocha, Steven D.; Saha, Sukamal S.; Wiese, David; Thompson, Jim; Morton, Donald L.; Bilchik, Anton J.
PUB. DATE
October 2003
SOURCE
American Surgeon;Oct2003, Vol. 69 Issue 10, p918
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Although the expression of thymidylate synthase (TS) in metastatic colorectal cancer (CRC) may be a better predictor of response to 5-fluorouracil chemotherapy than TS expression in primary CRC, this enzyme has not been well studied in tumor-draining regional lymph nodes. We retrospectively examined TS expression in 12 primary CRC lesions (pT3) and matched sentinel lymph nodes. Of the 8 primary tumors that were TS-positive, 50 per cent (4/8) had tumor-positive lymph nodes and 50 per cent (4/8) had tumor-negative nodes. Of the 4 primary tumors that were TSnegative, 75 per cent (3/4) had tumor-positive nodes and 25 per cent (1/4) had tumor-negative nodes [κ = -0.1386, 95 per cent confidence interval: (-0.4820, 0.2048), P = 0.4284]. Of the 8 TSpositive primaries, 25 per cent (2/8) had TS-positive nodes and 75 per cent (6/8) had TS-negative nodes. Of the 4 TS-negative primaries, 50 per cent (2/4) had TS-positive nodes and 50 per cent (2/4) had TS-negative nodes [κ = -0.0131, 95 per cent confidence interval: (-0.2958, 0.2696), P = 0.9274]. Two of the three TS-negative primaries that had metastasized to regional lymph nodes were associated with TS-positive lymph nodes. Our findings indicate that expression of TS by a primary CRC does not correlate with nodal metastases or nodal TS expression. Nodal expression of TS may be important in predicting response to 5-fluorouracil when a primary CRC is TS-negative.
ACCESSION #
11855832

 

Related Articles

  • Identification of Sentinel Lymph Nodes in Colon Cancer Depends on the Amount of Dye Injected Relative to Tumor Size. Viehl, Carsten T.; Hamel, Christian T.; Marti, Walter R.; Guller, Ulrich; Eisner, Lukas; Stammberger, Uz; Terracciano, Luigi; Spichtin, Hans P.; Harder, Felix; Zuber, Markus // World Journal of Surgery;Dec2003, Vol. 27 Issue 12, p1285 

    Recent studies have shown that the sentinel lymph node (SLN) procedure might improve staging in colon cancer. However, low SLN identification and high false negative rates have also been reported. In a two-institution study, the SLN procedure with isosulfan blue 1% was performed according to a...

  • A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes. Fumagalli, Debora; Gavin, Patrick G.; Taniyama, Yusuke; Seung-Il Kim; Hyun-Joo Choi; Soonmyung Paik; Pogue-Geile, Katherine L. // BMC Cancer;2010, Vol. 10, p101 

    Background: An increasing number of studies show that genetic markers can aid in refining prognostic information and predicting the benefit from systemic therapy. Our goal was to develop a high throughput, costeffective and simple methodology for the detection of clinically relevant hot spot...

  • Impact of a scientific presentation on community treatment patterns for primary breast cancer. Giordano, Sharon H.; Zhigang Duan; Yong-Fang Kuo; Hortobagyi, Gabriel N.; Freeman, Jean; Goodwin, James S.; Duan, Zhigang; Kuo, Yong-Fang // JNCI: Journal of the National Cancer Institute;3/15/2006, Vol. 98 Issue 6, p382 

    Background: The publication of results from randomized clinical trials can have a dramatic effect on treatment patterns, but the impact of oral presentations at national scientific meetings is unknown. We investigated the temporal association between the oral presentation of the...

  • Use of Sentinel Node Mapping for Cancer of the Colon: 'To Map or Not to Map.'. Thomas, Kristen A.; Lechner, Jonathan; Shen, Perry; Waters, Gregory S.; Geisinger, Kim R.; Levine, Edward A. // American Surgeon;Jul2006, Vol. 72 Issue 7, p606 

    Sentinel lymph node (SLN) mapping has become a cornerstone of oncologic surgery because it is a proven method for identifying nodal disease in melanoma and breast cancer. In addition, it can ameliorate the surgical morbidity secondary to lymphadenectomy. However, experience with SLN mapping for...

  • New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. Gobbi, P. G.; Valentino, F.; Berardi, E.; Tronconi, C.; Brugnatelli, S.; Luinetti, O.; Moratti, R.; Corazza, G. R. // British Journal of Cancer;1/29/2008, Vol. 98 Issue 2, p328 

    The aim of this study was to verify through relative survival (an estimate of cancer-specific survival) the true prognostic factors of colorectal cancer. The study involved 506 patients who underwent locally radical resection. All the clinical, histological and laboratory parameters were...

  • Lymph Node Harvest in Emergent versus Elective Colon Resections. Lewis, Aaron; Akopian, Gabriel; Carillo, Sharon; Kaufman, Howard S. // American Surgeon;Oct2012, Vol. 78 Issue 10, p1049 

    Quality measures for prognostication of colon cancer include the removal of 12 or more lymph nodes during colon resection. The purpose of this study was to determine whether emergent surgery is associated with inadequate lymph node harvest. The National Cancer Database (NCDB) was queried for...

  • Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations. Pelz, Joerg OW; Doerfer, J; Dimmler, A; Hohenberger, W; Meyer, T // BMC Cancer;2006, Vol. 6, p162 

    Background: In selected patients with peritoneal carcinomatosis from colorectal cancer prognosis can be improved by hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The aim of this study was to evaluate the tumor response of peritoneal carcinomatosis in...

  • Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Rosenberg, R; Hoos, A; Mueller, J; Nekarda, H // British Journal of Cancer;11/15/2000, Vol. 83 Issue 10, p1323 

    The reported rates for tumour cell involvement in the locoregional lymph nodes of colorectal cancer vary greatly, depending on the method used and case selection. In order to further evaluate the clinical value of molecular biologic detection of tumour cells we investigated 102 histologically...

  • Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay. Lotspeich, Erkki; Schoene, Markus; Gerngroß, Heinz; Schmidt, Roland; Steinmann, Reinhard; Ramadani, Marco; Gansauge, Susanne // Langenbeck's Archives of Surgery;Oct2007, Vol. 392 Issue 5, p559 

    Postoperative treatment for colorectal cancer depends on tumor stage as defined by the International Union Against Cancer (UICC). Adjuvant chemotherapy is not recommended in patients without lymph node involvement (UICC stages I and II). As many as 20–30% of these patients, however, will...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics